Talis Biomedical Corporation TLIS

Set alert

Price alert · TLIS

All alert types
2.84 USD +2.84 —

Day range unavailable

52-week range unavailable

YTD
0.00%
1 year
+71.08%
Open
—
Prev close
0.00
Mkt cap
3.23M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.08
Beta
1.56
Short ratio
0.59
Inst. own
55.06%
Dividend
0.00
Ex-div date
Earnings
Dec 24, 2024
50-d avg
1.89
200-d avg
6.59
1y target
0.00

3M chart

Chart tools
Interval

Signals (1)
NameDateAgo
MACD: Sell SignalJan 9, 20269 months ago

Analyst view

Consensus: sell

Sell
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 0 hold · 1 sell
  • Strong buy0
  • Buy0
  • Hold0
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TLIS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-15.150.0%581.00K+1.6%0
Next quarter0.000.00 – 0.00-14.700.0%140.00K-82.4%0
Current year0.000.00 – 0.000.000.0%2.13M-55.7%0
Next year0.000.00 – 0.000.000.0%00.0%0

Upgrades and downgrades

The latest rating changes

TLIS analyst upgrades and downgrades
DateFirmActionFromTo
Aug 15, 2023BTIGMaintainedSellSell